Dosimetry-Driven Personalization of Radiopharmaceutical Therapies: Evidence and Opportunities. Wahl RL, Dewaraja YK. J Nucl Med 2026;67.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wahl RL, Dewaraja YK. Dosimetry-Driven Personalization of Radiopharmaceutical Therapies: Evidence and Opportunities. J Nucl Med 2026;67.
PMID: 42728103